[In vivo study of cellular immunity in patients with scleroderma]. 1984

Z Olszewska, and C Arkuszewska, and A Płuzańska

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012594 Scleroderma, Localized A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules. Dermatosclerosis,Morphea,Scleroderma, Circumscribed,Frontal Linear Scleroderma en Coup de Sabre,Linear Scleroderma,Scleroderma, Linear,Circumscribed Scleroderma,Localized Scleroderma,Morpheas,Sclerodermas, Localized
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

Z Olszewska, and C Arkuszewska, and A Płuzańska
January 1987, Terapevticheskii arkhiv,
Z Olszewska, and C Arkuszewska, and A Płuzańska
February 1983, Vrachebnoe delo,
Z Olszewska, and C Arkuszewska, and A Płuzańska
January 1988, Przeglad lekarski,
Z Olszewska, and C Arkuszewska, and A Płuzańska
April 1978, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
Z Olszewska, and C Arkuszewska, and A Płuzańska
March 1972, Annals of the rheumatic diseases,
Z Olszewska, and C Arkuszewska, and A Płuzańska
January 1976, Przeglad dermatologiczny,
Z Olszewska, and C Arkuszewska, and A Płuzańska
July 1985, Arthritis and rheumatism,
Z Olszewska, and C Arkuszewska, and A Płuzańska
October 1988, Revista espanola de las enfermedades del aparato digestivo,
Z Olszewska, and C Arkuszewska, and A Płuzańska
January 1973, Voprosy onkologii,
Z Olszewska, and C Arkuszewska, and A Płuzańska
June 1990, Annales de la Societe belge de medecine tropicale,
Copied contents to your clipboard!